HuagongsheHuagongshe Chemistry Print Report · For research reference only
Ethanol → 6-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)cyclopropyl)-3-pyridinecarboxylic acid
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Ethanol | HCID 702 | — |
| Reactant | Bardoxolone | HCID 400010 | — |
| Reactant | Bardoxolone Methyl | HCID 400769 | — |
| Reactant | Retinoic Acid | HCID 444795 | — |
| Solvent | Dimethyl Sulfoxide | HCID 679 | — |
| Product | 6-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)cyclopropyl)-3-pyridinecarboxylic acid | HCID 3922 | — |
Reaction Steps
Reagents. Stock solutions of CDDO and/or CDDO-Me at 10 mM in DMSO were stored at −20° C. Working solutions were prepared in DMSO and added directly to culture medium. ATRA was purchased from Sigma Chemical Co. (St. Louis, Mo.) and kept in 100% ethanol solution at −20° C. RXR-specific ligand LG-100268 was kindly provided by Dr. Richard Heyman. Caspase-3 inhibitor Z-DEVD-fmk and bongkrekic acid (BA) were obtained from Calbiochem (La Jolla, Calif.). Cyclosporin A (CyA) was purchased from Sandoz. Fas-signaling antibody CH11 and Fas-blocking antibody ZB4 were obtained from Immunotech (Miami, Fla.).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US07435755B2 |
| Source dataset | uspto-grants-2008_10 |
| ORD ID | ord-b45adcc08b6c4c37a67d8aa3725ea976 |
| Source note | uspto-grants-2008_10 |